BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Z, Bian E, Xu Y, Ji X, Tang F, Ma C, Wang H, Zhao B. Meg3 Induces EMT and Invasion of Glioma Cells via Autophagy. Onco Targets Ther 2020;13:989-1000. [PMID: 32099402 DOI: 10.2147/OTT.S239648] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang X, Xing L, Chen Y, Qin R, Song S, Lu Y, Xie S, Wang L, Pu H, Gui X, Li T, Xu J, Li J, Jia S, Lu D. CircMEG3 inhibits telomerase activity by reducing Cbf5 in human liver cancer stem cells. Mol Ther Nucleic Acids 2021;23:310-23. [PMID: 33425489 DOI: 10.1016/j.omtn.2020.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Jacquet M, Hervouet E, Baudu T, Herfs M, Parratte C, Feugeas JP, Perez V, Reynders C, Ancion M, Vigneron M, Baguet A, Guittaut M, Fraichard A, Despouy G. GABARAPL1 Inhibits EMT Signaling through SMAD-Tageted Negative Feedback. Biology (Basel) 2021;10:956. [PMID: 34681055 DOI: 10.3390/biology10100956] [Reference Citation Analysis]
3 Gao Q, Chang X, Yang M, Zheng J, Gong X, Liu H, Li K, Wang X, Zhan H, Li S, Feng S, Sun X, Sun Y. LncRNA MEG3 restrained pulmonary fibrosis induced by NiO NPs via regulating hedgehog signaling pathway-mediated autophagy. Environ Toxicol 2022;37:79-91. [PMID: 34608745 DOI: 10.1002/tox.23379] [Reference Citation Analysis]
4 Fan Y, Wang Y, Zhang J, Dong X, Gao P, Liu K, Ma C, Zhao G. Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment. Front Immunol 2021;12:746621. [PMID: 34671362 DOI: 10.3389/fimmu.2021.746621] [Reference Citation Analysis]
5 Zhang Q, Yang L, Guan G, Cheng P, Cheng W, Wu A. LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT. Front Oncol 2020;10:569584. [PMID: 33194658 DOI: 10.3389/fonc.2020.569584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xu X, Zhong Z, Shao Y, Yi Y. Prognostic Value of MEG3 and Its Correlation With Immune Infiltrates in Gliomas. Front Genet 2021;12:679097. [PMID: 34220951 DOI: 10.3389/fgene.2021.679097] [Reference Citation Analysis]
7 DeSouza PA, Qu X, Chen H, Patel B, Maher CA, Kim AH. Long, Noncoding RNA Dysregulation in Glioblastoma. Cancers (Basel) 2021;13:1604. [PMID: 33807183 DOI: 10.3390/cancers13071604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Momtazmanesh S, Rezaei N. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review. Front Oncol 2021;11:712786. [PMID: 34322395 DOI: 10.3389/fonc.2021.712786] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Mukherjee S, Pillai PP. Current insights on extracellular vesicle-mediated glioblastoma progression: Implications in drug resistance and epithelial-mesenchymal transition. Biochim Biophys Acta Gen Subj 2021;1866:130065. [PMID: 34902452 DOI: 10.1016/j.bbagen.2021.130065] [Reference Citation Analysis]
10 Listro R, Stotani S, Rossino G, Rui M, Malacrida A, Cavaletti G, Cortesi M, Arienti C, Tesei A, Rossi D, Giacomo MD, Miloso M, Collina S. Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. Front Chem 2020;8:495. [PMID: 32695745 DOI: 10.3389/fchem.2020.00495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]